Kimi Goldstein

Kimi Goldstein has a diverse work experience spanning multiple industries. Starting in 2011, they were a Biomedical Engineering Research Intern at the University of Minnesota. In 2012, they worked as a Business Development Associate at BioEnterprise, where they evaluated new technologies in biotechnology, medical device, and healthcare IT industries. From 2013 to 2014, they were an Investment Banking Summer Analyst - Healthcare at Barclays. In 2014, they joined Oliver Wyman as a Consultant, eventually rising to the role of Associate. Kimi transitioned to Bright Health in 2017, where they held various positions, including Business Development Associate, Senior Associate in Care Partner Development, and Manager in Care Partner Development. In 2020, they pursued an MBA at Harvard Business School and concurrently served as a Flare Capital Scholar at Flare Capital Partners. Kimi also completed an MBA internship in Population Health at Oak Street Health in 2021. Currently, they are the Director of Population Health at Oak Street Health.

Kimi Goldstein completed a Master of Business Administration (MBA) degree from Harvard Business School between 2020 and 2022. Prior to that, Kimi obtained a Bachelor of Science (B.S.) degree in Biomedical/Medical Engineering from Yale University. Kimi's earlier education history is not provided.